HEMO Invest ApS: Financial statements 2024
CVR: 38403125
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -34,923 and a net result of DKK 2,192,878 compared with DKK 1,477,442 the year before. Equity in the 2024 report amounted to DKK 29,854,634. The solvency ratio was 99.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -34,923
- Profit/Loss
- DKK 2,192,878
- Equity
- DKK 29,854,634
- Total Assets
- DKK 29,940,802
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -35K | 2.2M | 29.9M | 1 |
| 2023 | - | -62K | 1.5M | 28.3M | 1 |
| 2022 | - | -29K | -3.1M | 27.6M | - |
| 2021 | - | -55K | 17.2M | 30.8M | - |
| 2020 | - | -43K | 8.9M | 13.7M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HEMO Invest ApS has published its annual report for 2023. Gross profit came to DKK -61,839, and the net result was DKK 1,477,442.
About HEMO Invest ApS
HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.
